Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling-Reference-Cited by-同舟云学术

Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling

Published:2014-03-28 Issue:8 Volume:135 Page:1822-1831
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Reifenberger Guido¹,Weber Ruthild G.²,Riehmer Vera²,Kaulich Kerstin¹,Willscher Edith³,Wirth Henry³,Gietzelt Jens⁴,Hentschel Bettina⁴,Westphal Manfred⁵,Simon Matthias⁶,Schackert Gabriele⁷,Schramm Johannes⁶,Matschke Jakob⁸,Sabel Michael C.⁹,Gramatzki Dorothee¹⁰,Felsberg Jörg¹,Hartmann Christian¹¹¹²,Steinbach Joachim P.¹³¹⁴,Schlegel Uwe¹⁵,Wick Wolfgang¹⁶,Radlwimmer Bernhard¹⁷,Pietsch Torsten¹⁸,Tonn Jörg C.¹⁹,von Deimling Andreas¹²,Binder Hans³,Weller Michael¹⁰¹⁴,Loeffler Markus⁴,

Affiliation:

1. Department of Neuropathology; Heinrich Heine University, Düsseldorf, and German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ); Heidelberg Germany

2. Department of Human Genetics; Hannover Medical School; Hannover Germany

3. Interdisciplinary Institute for Bioinformatics; University of Leipzig; Germany

4. Institute for Medical Informatics Statistics and Epidemiology; University of Leipzig; Germany

5. Department of Neurosurgery; University Hospital Hamburg-Eppendorf; Hamburg Germany

6. Department of Neurosurgery; University of Bonn Medical School; Bonn Germany

7. Department of Neurosurgery; Technical University Dresden; Germany

8. Institute of Neuropathology; University Hospital Hamburg-Eppendorf; Hamburg Germany

9. Department of Neurosurgery; Heinrich Heine University; Düsseldorf Germany

10. Department of Neurology; University Hospital Zurich; Switzerland

11. Department of Neuropathology Institute of Pathology; Hannover Medical School; Hannover Germany

12. Department of Neuropathology Institute of Pathology; University Hospital Heidelberg, and Clinical Cooperation Unit Neuropathology, DKFZ; Heidelberg Germany

13. Dr. Senckenberg Institute of Neurooncology; University Hospital Frankfurt; Germany

14. Department of General Neurology; University Hospital Tübingen; Germany

15. Department of Neurology; University Hospital Knappschaftskrankenhaus Bochum-Langendreer; Bochum Germany

16. Department of Neurooncology Neurology Clinic and National Center for Tumor Diseases; University Hospital Heidelberg; Germany

17. Division of Molecular Genetics; DKFZ; Heidelberg Germany

18. Department of Neuropathology; University of Bonn Medical School; Bonn Germany

19. Department of Neurosurgery; Ludwig Maximilians University Munich; Germany

Funder

German Cancer Aid

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009;Dolecek;Neuro Oncol,2012

2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

3. Glioblastoma survival in the United States before and during the temozolomide era;Johnson;J Neurooncol,2012

4. A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme;Rønning;Neuro Oncol,2012

5. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma. A prospective translational study of the German Glioma Network;Weller;J Clin Oncol,2009

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabotropic Glutamate Receptors Type 3 and 5 Feature the “NeuroTransmitter-type” of Glioblastoma: A Bioinformatic Approach;Current Neuropharmacology;2024-09

2. Magnetic resonance imaging (MRI)-based intratumoral and peritumoral radiomics for prognosis prediction in glioma patients;Clinical Radiology;2024-08

3. Network‐Based Transcriptome Analysis Reveals FAM3C as a Novel Potential Biomarker for Glioblastoma;Journal of Cellular Biochemistry;2024-06-25

4. Second surgery for relapsed glioblastoma: an observational study on criteria for patient selection in real life;Future Oncology;2024-06-11

5. Clinical and molecular features of patients with IDH1 wild-type primary glioblastoma presenting unexpected short-term survival after gross total resection;Journal of Neuro-Oncology;2024-06-05